St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Sabrin Albeituni, PhD
Sr. Scientist
On this page:
Contact Information
Sabrin Albeituni, PhD
Cancer Predisposition
MS 343, Room D4022
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Affiliations
Education
BS - Birzeit University, West Bank, Palestine MS - University of Louisville, Louisville, Kentucky PhD - University of Louisville, Louisville, Kentucky
Honors & Awards
- 2019 Milstein Travel Award-International Cytokine and Interferon Society
- 2018 Milstein Travel Award-International Cytokine and Interferon Society
- 2018 Stemcell Technologies’AAI 2018 Travel Award
- 2018 American Association of Immunologists (AAI) Trainee Abstract Award
- 2017 American Association of Immunologists (AAI) Trainee Abstract Award
- 2015 American Association of Immunologists (AAI) Trainee Abstract Award
- 2015 John Richard Binford Memorial Award
- 2015 Graduate Dean’s Citation, Commencement Award- Fall 2015
- 2014 Condict Moore Graduate Student Research Award -First Place - James Graham Brown Cancer Center Annual Research Retreat
- 2013 Michael K. Tanner Award for Excellence in Graduate Student Sciences - University of Louisville
- 2010-2012 Fulbright Scholarship
Research Interests
I am a Sr. Scientist with a strong interest in understanding the regulation of T cell responses by myeloid cells during normal immune homeostasis and in conditions of hyperinflammation. My research focuses on investigating the cellular and molecular mechanisms driving the pathogenesis of hemophagocytic lymphohistiocytosis (HLH)- a severe hyperinflammatory syndrome characterized by excessive immune cell activation and multi-system organ failure. In the Nichols’ laboratory, our goal is to advance innovative therapeutic strategies to mitigate hyperinflammation and improve clinical outcomes in patients with HLH.